Jin10 Data reported on August 21 that Menco Pharmaceutical announced that shareholders JSR Limited and Best Idea International Limited plan to participate in the pre-IPO shareholder Inquiry transfer, intending to transfer a total of 22,946,200 shares, accounting for 3.50% of Menco Pharmaceutical’s total share capital. This transfer is a private transfer, with the transferee being institutional investors with corresponding pricing capabilities and risk tolerance. The lower limit of the transfer price shall not be less than 70% of the average trading price of the stocks in the 20 trading days prior to the date of sending the subscription invitation (i.e., August 21, 2025, inclusive).
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.